US FDA approves home-delivered tDCS for treating depression
On Dec 8, 2025, the US Food and Drug Administration (FDA) approved the Flow Neuroscience transcranial Direct Current Stimulation (tDCS) device for the treatment of “moderate to severe major depressive disorder (MDD) in the current episode, either as monotherapy or as an adjunctive treatment, in pati...
Zapisane w:
| Główni autorzy: | , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Elsevier
2026-01-01
|
| Seria: | Brain Stimulation |
| Dostęp online: | http://www.sciencedirect.com/science/article/pii/S1935861X25004231 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|